[1] ECHELMAN D,FELDMAN S. Management of cervical precancers:A global perspective[J]. Hematol Oncol Clin North Am,2012,26(1):31-44. [2] MIN-A K,JIN-KYOUNG O,BO W K,et al. Prevalence and seroprevalence of low-risk human papillomavirus in Korean women[J]. J Korean Med Sci,2012,27(8):922. [3] SASAGAWA T,TAKAGI H,MAKINODA S. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer[J]. J Infect Chemother, 2012,18(6):807-815. [4] CASTELLSAGUé X. Natural history and epidemiology of HPV infection and cervical cancer[J]. Gynecol Oncol,2008;110(3 Sup 2):4-7. [5] 阿比班·阿克拉,Abulizi Abudula. 维吾尔族妇女宫颈癌与TFPI2基因启动子甲基化的关系研究[J]. 中国肿瘤临床,2013,40(2):76-80. [6] 吐尔逊帕夏·吾布力卡斯木,阿比达·阿布都卡德尔,盛磊,等. 维吾尔族妇女宫颈病变与CALCA基因启动子甲基化的关系[J]. 癌变·畸变·突变,2013,25(2):134-138. [7] 盛磊,阿仙姑·哈斯木,刘开江,等. 维吾尔族妇女宫颈病变病理进程与降钙素相关肽α表达的关系[J]. 癌变·畸变·突变,2011,23(4):287-290. [8] CASTLE P E,MAZA M. Prophylactic HPV vaccination:past,present,and future[J]. Epidemiol Infect,2016,144(3):449-468. [9] WENTZENSEN N,SCHIFFMAN M,PALMER T,et al. Triage of HPV positive women in cervical cancer screening[J]. J Clin Virol,2016,76 Sup 1:49-55. [10] MANZO-MERINO J,THOMAS M,FUENTES-GONZALEZ A M,et al. HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers[J]. Expert Opin Ther Targets,2013,17(11):1357-1368. [11] DE FREITAS A C,COIMBRA E C,LEITÃO M C. Molecular targets of HPV oncoproteins:potential biomarkers for cervical carcinogenesis[J]. Biochim Biophys Acta,2014,1845(2):91-103. [12] LI X,MIAO X,WANG H,et al. The tissue dependent interactions between p53 and Bcl-2 in vivo[J]. Oncotarget,2015,6(34):35699-35709. [13] BESBES S,MIESHANI M,POCARD M,et al. New dimension in therapeutic targeting of BCL-2 family proteins[J]. Oncotarget,2015,6(15):12862-12871. [14] PATERNOT S,BOCKSTAELE L,BISTEAU X,et al. Rb inactivation in cell cycle and cancer:the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase[J]. Cell Cycle,2010,9(4):689-699. [15] 刘深基,陈松森. 降钙素/降钙素基因相关肽基因前体RNA的加工[J]. 医学分子生物学杂志,1999,21(4):196-200. [16] HU S,EWERTZ M,TUFANO R P,et al. Detection of serum deoxyribonucleic acid methylation markers:a novel diagnostic tool for thyroid cancer[J]. J Clin Endocr Metab,2006,91(1):98-104. [17] WIDSCHWENDTER A,MULLER H M,Fiegl H,et al. DNA methylation in serum and tumors of cervical cancer patients[J]. Clin Cancer Res,2004,10(2):565-571. [18] WISMAN G,NIJHUIS E,HOQUE M,et al. Assessment of gene promoter hypermethylation for detection of cervical neoplasia[J]. Int J Cancer,2006,119(8):1908-1914. [19] CHAND H S,SCHMIDT A E,BAJAJ S P,et al. Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2[J]. J Biol Chem,2004,279(17):17500-17507. [20] DU X.DENG F M,Chand H S,et al.Molecular cloning,expression,and characterization of bovine tissue factor pathway inhibitor-2[J].Arch Biochem Biophys,2003,417(1):96-104. [21] POPOV N,GIL J.Epigenetic regulation of the INK4b-ARF-INK4a locus:in sickness and in health[J]. Epigenetics,2010,5(8):685-690. [22] STANLEY M A. Establishing HPV-containing keratinocyte cell lines from tissue biopsies[J]. Methods Mol Med,2005,119:129-139. [23] 董海龙,隋延仿,曲萍,等. 人子宫颈鳞状细胞癌细胞系HCC-0214的建立及其生物学特性[J]. 中华肿瘤杂志,2003,25(1):43-46. [24] 曹泽毅,赵健,廖秦平,等. 人乳头状瘤病毒16型E6、E7基因诱导的人子宫颈永生化上皮细胞系的建立及其生物学特性的鉴定[J]. 中华妇产科杂志,2004,39(7):486-488. |